2022
DOI: 10.3389/fnmol.2022.886729
|View full text |Cite
|
Sign up to set email alerts
|

Loss, Gain and Altered Function of GlyR α2 Subunit Mutations in Neurodevelopmental Disorders

Abstract: Glycine receptors (GlyRs) containing the α2 subunit govern cell fate, neuronal migration and synaptogenesis in the developing cortex and spinal cord. Rare missense variants and microdeletions in the X-linked GlyR α2 subunit gene (GLRA2) have been associated with human autism spectrum disorder (ASD), where they typically cause a loss-of-function via protein truncation, reduced cell-surface trafficking and/or reduced glycine sensitivity (e.g., GLRA2Δex8-9 and extracellular domain variants p.N109S and p.R126Q). H… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 76 publications
0
7
0
Order By: Relevance
“…Regarding Btg2, only a slight but significant decrease in the expression levels was registered in the Epm2a−/− mice. All the genes analyzed are somehow related to molecular pathways relevant to the pathophysiological context of LD: Nsun3 (NOP2/Sun RNA methyltransferase 3) encodes a mitochondrial methyltransferase related to encephalomyopathy and seizures [ 18 ]; Glra2 (glycine receptor alpha 2) encodes for a glycine receptor that has been predicted to influence cognition, learning, and memory in the developing brain [ 19 ]; Btg2 (BTG anti-proliferation factor 2) is an anti-proliferative gene that, interestingly, has been postulated as a neuroprotective gene in mouse models of Huntington’s disease [ 20 ]; and Traf6 (TNF receptor-associated factor 6) is an immune response regulator with an E3 ubiquitin ligase activity that has been shown to interact with Sod1 in rat models of amyotrophic lateral sclerosis (ALS), promoting aggregation [ 21 ].…”
Section: Resultsmentioning
confidence: 99%
“…Regarding Btg2, only a slight but significant decrease in the expression levels was registered in the Epm2a−/− mice. All the genes analyzed are somehow related to molecular pathways relevant to the pathophysiological context of LD: Nsun3 (NOP2/Sun RNA methyltransferase 3) encodes a mitochondrial methyltransferase related to encephalomyopathy and seizures [ 18 ]; Glra2 (glycine receptor alpha 2) encodes for a glycine receptor that has been predicted to influence cognition, learning, and memory in the developing brain [ 19 ]; Btg2 (BTG anti-proliferation factor 2) is an anti-proliferative gene that, interestingly, has been postulated as a neuroprotective gene in mouse models of Huntington’s disease [ 20 ]; and Traf6 (TNF receptor-associated factor 6) is an immune response regulator with an E3 ubiquitin ligase activity that has been shown to interact with Sod1 in rat models of amyotrophic lateral sclerosis (ALS), promoting aggregation [ 21 ].…”
Section: Resultsmentioning
confidence: 99%
“…In the adulthood, glycinergic neurotransmission is limited to the spinal cord, retina and few brain areas; however, functional GlyRs have been found almost everywhere in the developing brain. Moreover a variety of evidence strongly support a relevant role of glycine signaling during development; even more, alterations in this signaling has been associated to pathologies in the adulthood (Eichler et al, 2008;Bode and Lynch, 2013;Piton et al, 2013;Pilorge et al, 2016;Morelli et al, 2017;Chen et al, 2022) supporting glycinergic function in proliferation and cell specification and circuit formation. Though, few studies have been carried out to analyze the mechanisms involved.…”
Section: Cns Development Involved Precise Coordination Of Cell Prolif...mentioning
confidence: 99%
“…Furthermore, recently Chen et al ( 2022) using a combination of molecular modeling and electrophysiology recordings for four novel missense variants in GLRA2 associated with autism spectrum disorder (ASD), identified GLRA2 as the cause of autism spectrum neurodevelopmental phenotypes. The missense variants cause either loss, gain or altered function of GlyR α2 subunit, enlightening the clinical forms associated with human ASD (Chen et al, 2022).…”
Section: Pathophysiological Consequences Of Glycinergic Action During...mentioning
confidence: 99%
“…Recent investigations have noted that missense variants in this gene can result in a loss, gain, or altered function of the encoded protein. In turn, missense variants are likely to either negatively or positively deregulate cortical progenitor homeostasis and neuronal migration in the developing brain, leading to changes in cognition, learning, and memory [21]. The most associated disorder with GLRA2 is X-Linked Intellectual Developmental Disorder, Syndromic, Pilorge Type (MRXSP, OMIM: 301076).…”
Section: Variant Interpretationmentioning
confidence: 99%